Fast work by GSK to get IDX899 listed when, technically, the GSK-IDIX collaboration had not even closed yet when this pdf file was created!
Of greater consequence to IDIX investors is that GSK’s HIV pipeline includes two integrase inhibitors: ‘1349572’ in phase-2 (#msg-35640675) and ‘1265744’ in phase-1.
Market Data 
Markets 
AI
